Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) Net Margin (2020 - 2024)

Agilon Health (AGL) has disclosed Net Margin for 6 consecutive years, with 0.89% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 96.0% year-over-year to 0.89%, compared with a TTM value of 0.24% through Dec 2025, up 41.0%, and an annual FY2025 reading of 0.24%, up 40.0% over the prior year.
  • Net Margin was 0.89% for Q4 2025 at Agilon Health, up from 1.0% in the prior quarter.
  • Across five years, Net Margin topped out at 0.91% in Q1 2025 and bottomed at 14.02% in Q4 2021.
  • Average Net Margin over 5 years is 1.24%, with a median of 0.07% recorded in 2023.
  • The sharpest move saw Net Margin plummeted -1794bps in 2021, then soared 1388bps in 2022.
  • Year by year, Net Margin stood at 14.02% in 2021, then soared by 99bps to 0.14% in 2022, then crashed by -4631bps to 6.4% in 2023, then surged by 99bps to 0.07% in 2024, then skyrocketed by 1380bps to 0.89% in 2025.
  • Business Quant data shows Net Margin for AGL at 0.89% in Q4 2025, 1.0% in Q2 2025, and 0.91% in Q1 2025.